Search for: "Application of American Cyanamid Company" Results 21 - 35 of 35
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Dec 2016, 11:31 am by Lawrence B. Ebert
American Cyanamid,774 F.2d 448 (CAFC 1985) Judge Giles Rich wrote:The issue of obviousness is determined entirely with reference to a hypothetical "person having ordinary skill in the art. [read post]
4 Jul 2013, 1:47 am
Birss J granted the claimants' applications and allowed all but one of the claimants' requests for redaction. [read post]
3 Apr 2012, 2:45 pm by Curtis E. Marble
Potential Significance Canadian Courts have long paid close attention to English injunction cases (most notably, of course, American Cyanamid). [read post]
3 May 2007, 6:29 pm
American Cyanamid Co.: "one who thinks along the line of conventional wisdom in the art and is not one who undertakes to innovate, whether by patient, and often expensive, systematic research or by extraordinary insights, it makes no difference which. [read post]
5 Jun 2016, 11:05 pm
 The American Cyanamid principles also apply (i.e. serious question to be tried, adequacy of damages, balance of convenience and whether the status quo should be maintained).The decisionThe judge found that the balance of convenience favored granting the interim relief. [read post]
21 Jun 2010, 2:00 am by Adam Wagner
Good arguable claim The context of applying for an interim injunction is important: an applicant need only show that they have a “good arguable claim“; the hearing is not intended to represent a full hearing of the merits of the case (see American Cyanamid Co. v. [read post]
  The UK court assesses PIs by asking three (or four depending how you break them down) questions (arising from American Cyanamid): (1) is there a serious issue to be tried / is there an arguable case? [read post]
20 Mar 2009, 2:05 am
Superior Court, 751 P.2d 470 (1988):Thus far the courts have tended to hold the manufacturer to a high standard of care in preparing and testing drugs of unknown potentiality and in giving warning; but in the absence of evidence that this standard has not been met, they have refused to hold the maker liable for unforeseeable harm.Id. at 479 (reaffirming state-of-the-art defense in design defect context).For these same reasons of policy, we reject plaintiff's assertion that a drug manufacturer… [read post]
25 Jan 2010, 5:00 am by Beck, et al.
  So we decided to take an in-depth look at all of the the precedent that rejects application of a “fraud on the market” reliance presumption to state-law claims.Just to make sure that everyone’s with us, briefly “fraud on the market” is a doctrine that waters down fraud (and, plaintiffs would like to say, other liability theories based on claimed misinformation) by presuming reliance in certain limited circumstances. [read post]
2 Jun 2011, 12:46 pm by Bexis
American Cyanamid Co., 718 P.2d 1318, 1324 (Kan. 1986); Wooderson v. [read post]
19 Sep 2013, 9:53 am by Bexis
  By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]